| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | +814.1% |
| Cost of Revenue | $53K | — |
| Gross Profit | $1.2M | +774.8% |
| R&D Expense | $7.5M | -17.4% |
| SG&A Expense | $5.8M | -34.2% |
| Operating Income | -$12.2M | +31.8% |
| Pre-tax Income | -$12.1M | +51.1% |
| Income Tax | $3K | +0.0% |
| Net Income | -$12.2M | +51.1% |
| EPS (Basic) | -$5.86 | +11.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $237K | +111.6% |
| Inventory | $66K | — |
| Current Assets | $13.6M | +260.6% |
| Total Assets | $14.2M | +204.0% |
| Current Liabilities | $3.7M | -45.3% |
| Total Liabilities | $3.7M | -45.3% |
| Stockholders' Equity | $10.4M | +577.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.6M | +15.0% |
| Financing Cash Flow | $23.8M | +34.6% |